Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A3CMGM5
Wed, 20.08.2025
APONTIS PHARMA AG
APONTIS PHARMA: Changes in the management board
Monheim am Rhein, 20 August 2025. Bruno Wohlschlegel, CEO of APONTIS PHARMA AG (ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company for single-pill combinations in Germany, is to leave the company at the end of August 2025 with the end of his contract. Wohlschlegel will take on an advis [ … ]
Thu, 15.05.2025
APONTIS PHARMA AG
APONTIS PHARMA publishes results for the first quarter of 2025 and confirms forecast for 2025
Group sales rise to EUR 12.9 million in Q1 2025 (3M 2024: EUR 10.0 million)
Single Pill combinations grew strongly overall by EUR 0.6 million. The portfolio more than compensated for the tender-related decline of EUR 1.0 million at Tonotec.
Further im [ … ]
Mon, 31.03.2025
APONTIS PHARMA AG
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned
Sales increases significantly to EUR 48.5 million in 2024 financial year (2023: EUR 37.0 million)
Strong increase in Single Pill combination revenues to EUR 34.4 million (2023: EUR 25.6 million)
EBITDA increases by EUR 16.8 mill [ … ]
